Phenformin (CAS 114-86-3) Global Market Research Report 2024

About the Phenformin Market

Phenformin is a drug used in animal pharmaceuticals to treat diabetes in animals. It is a biguanide, a type of oral hypoglycemic agent, and is used to reduce blood glucose levels in animals with diabetes. It is commonly used in cats, dogs, horses, and other animals. It works by decreasing the amount of glucose produced by the liver and increasing the sensitivity of the body's cells to insulin. Phenformin is available in both tablet and liquid form, and is typically administered orally. It is generally well-tolerated, but can cause side effects such as vomiting, diarrhea, and anorexia. It is important to monitor the animal's blood glucose levels closely when using this drug, as it can cause hypoglycemia if not used properly. The Phenformin market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, and Zoetis. Show Less Read more